scorecardresearch
Covid-19: Bharat Biotech, Duc Minh donate 2 lakh Covaxin doses to Vietnam

Covid-19: Bharat Biotech, Duc Minh donate 2 lakh Covaxin doses to Vietnam

In Vietnam, Bharat Biotech has been working with Duc Minh Medical JSC, towards the commercialization of INDIRAB (Inactivated Rabies Vaccine).

Covid-19: Bharat Biotech, Duc Minh donate 2 lakh Covaxin doses to Vietnam (Photo: Reuters) Covid-19: Bharat Biotech, Duc Minh donate 2 lakh Covaxin doses to Vietnam (Photo: Reuters)

The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech’s COVID-19 vaccine, a top official of the company said on Thursday.

The announcement was made by Suchitra Ella, Joint Managing Director of Bharat Biotech at a function hosted by Virong Dinh Hue, President of the National Assembly of the Socialist Republic of Vietnam in the national capital.

According to a release by the vaccine maker, the donation represents a gesture of goodwill to provide access to Bharat Biotech’s Covaxin to fight COVID- 19 pandemic across borders.

Covaxin has received Emergency Use Listing (EUL) in Vietnam also. In Vietnam, Bharat Biotech has been working with Duc Minh Medical JSC, towards the commercialization of INDIRAB (Inactivated Rabies Vaccine). Duc Minh is Bharat Biotech’s local partner in Vietnam.

Bharat Biotech was invited by the Embassy of Vietnam for a one-on-one meeting with the President of the National Assembly, to discuss avenues of cooperation, supplies, and technology transfer possibilities.

“It is an honour for us to serve the Republic of Vietnam in a humble manner and wish Covaxin contribution will help boost up the country’s national vaccination program and recovery from the pandemic. We also like to thank H.E of Vietnam for inviting us to meet and discuss opportunities for collaboration,” Ella said.

“We believe in vaccine equity, global public health, and having access to the vaccine is vital for national health, and I hope everyone in the Republic of Vietnam will take advantage of having access to the widely administered, safe and efficacious Covaxin,” Krishna Ella, Chairman and Managing Director of Bharat Biotech said.

Bharat Biotech has completed Phase 2 and 3 trials of Covaxin for children in the age group 2 to 18 years. The data has been submitted to the Central Drugs Standard Control Organisation (CDSCO) and the final approval is awaited. On approval, children will also have access to the jab.

Bharat Biotech has also supplied INDIRAB to the Republic Nation supporting their national rabies vaccine requirement, the release said.

Also Read: WHO panel outlines recommendations for Covid-19 booster shots

Also Read: Suchitra Ella: The Vaccine Lady

Published on: Dec 16, 2021, 9:18 PM IST
Posted by: Tarab Zaidi, Dec 16, 2021, 9:13 PM IST